EMS-CHEMIE HOLDING AG

SWX:EMSN Stock Report

Market Cap: CHF 15.3b

EMS-CHEMIE HOLDING Valuation

Is EMSN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EMSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CHF 559.49
Fair Value
17.3% overvalued intrinsic discount
8
Number of Analysts

Below Fair Value: EMSN (CHF656) is trading above our estimate of fair value (CHF559.49)

Significantly Below Fair Value: EMSN is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMSN?

Key metric: As EMSN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for EMSN. This is calculated by dividing EMSN's market cap by their current earnings.
What is EMSN's PE Ratio?
PE Ratio32.9x
EarningsCHF 466.00m
Market CapCHF 15.34b

Price to Earnings Ratio vs Peers

How does EMSN's PE Ratio compare to its peers?

The above table shows the PE ratio for EMSN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average31.5x
GIVN Givaudan
34.4x6.6%CHF 37.4b
SIKA Sika
31.1x7.9%CHF 38.8b
CLN Clariant
30.4x32.8%CHF 3.6b
SIGN SIG Group
30.1x11.3%CHF 7.8b
EMSN EMS-CHEMIE HOLDING
32.9x4.9%CHF 15.3b

Price-To-Earnings vs Peers: EMSN is expensive based on its Price-To-Earnings Ratio (32.9x) compared to the peer average (31.5x).

Price to Earnings Ratio vs Industry

How does EMSN's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
EMSN 32.9xIndustry Avg. 18.5xNo. of Companies10PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: EMSN is expensive based on its Price-To-Earnings Ratio (32.9x) compared to the European Chemicals industry average (18.5x).

Price to Earnings Ratio vs Fair Ratio

What is EMSN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMSN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.9x
Fair PE Ratio22.4x

Price-To-Earnings vs Fair Ratio: EMSN is expensive based on its Price-To-Earnings Ratio (32.9x) compared to the estimated Fair Price-To-Earnings Ratio (22.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EMSN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 656.00
CHF 694.25
+5.8%
9.2%CHF 800.00CHF 600.00n/a8
Feb ’26CHF 646.50
CHF 709.57
+9.8%
9.7%CHF 800.00CHF 634.00n/a7
Jan ’26CHF 611.50
CHF 709.57
+16.0%
9.7%CHF 800.00CHF 634.00n/a7
Dec ’25CHF 626.50
CHF 712.86
+13.8%
9.2%CHF 800.00CHF 650.00n/a7
Nov ’25CHF 676.50
CHF 735.71
+8.8%
11.7%CHF 900.00CHF 650.00n/a7
Oct ’25CHF 707.00
CHF 730.63
+3.3%
11.4%CHF 900.00CHF 633.00n/a8
Sep ’25CHF 711.50
CHF 730.63
+2.7%
11.4%CHF 900.00CHF 633.00n/a8
Aug ’25CHF 733.50
CHF 730.63
-0.4%
11.4%CHF 900.00CHF 633.00n/a8
Jul ’25CHF 739.50
CHF 675.00
-8.7%
10.5%CHF 800.00CHF 580.00n/a7
Jun ’25CHF 744.00
CHF 667.14
-10.3%
9.6%CHF 800.00CHF 580.00n/a7
May ’25CHF 737.00
CHF 664.29
-9.9%
9.8%CHF 800.00CHF 580.00n/a7
Apr ’25CHF 692.00
CHF 664.29
-4.0%
9.8%CHF 800.00CHF 580.00n/a7
Mar ’25CHF 624.00
CHF 655.71
+5.1%
12.2%CHF 800.00CHF 547.00n/a7
Feb ’25CHF 658.00
CHF 657.14
-0.1%
12.5%CHF 800.00CHF 547.00CHF 646.507
Jan ’25CHF 681.00
CHF 657.14
-3.5%
12.5%CHF 800.00CHF 547.00CHF 611.507
Dec ’24CHF 621.50
CHF 657.14
+5.7%
12.5%CHF 800.00CHF 547.00CHF 626.507
Nov ’24CHF 621.50
CHF 704.57
+13.4%
11.4%CHF 850.00CHF 613.00CHF 676.507
Oct ’24CHF 623.00
CHF 704.57
+13.1%
11.4%CHF 850.00CHF 613.00CHF 707.007
Sep ’24CHF 665.50
CHF 700.29
+5.2%
11.6%CHF 850.00CHF 613.00CHF 711.507
Aug ’24CHF 726.00
CHF 700.71
-3.5%
11.5%CHF 850.00CHF 613.00CHF 733.507
Jul ’24CHF 677.00
CHF 712.86
+5.3%
14.3%CHF 900.00CHF 560.00CHF 739.507
Jun ’24CHF 704.50
CHF 716.43
+1.7%
14.5%CHF 900.00CHF 575.00CHF 744.007
May ’24CHF 731.50
CHF 720.71
-1.5%
14.5%CHF 900.00CHF 575.00CHF 737.007
Apr ’24CHF 754.00
CHF 722.57
-4.2%
14.4%CHF 900.00CHF 575.00CHF 692.007
Mar ’24CHF 717.00
CHF 702.50
-2.0%
15.1%CHF 900.00CHF 575.00CHF 624.006
Feb ’24CHF 683.00
CHF 684.17
+0.2%
16.6%CHF 900.00CHF 575.00CHF 658.006
Analyst Price Target
Consensus Narrative from 8 Analysts
CHF 694.25
Fair Value
5.5% undervalued intrinsic discount
8
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/15 01:09
End of Day Share Price 2025/02/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EMS-CHEMIE HOLDING AG is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Aron CeccarelliBerenberg